ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
Dow Jones
40.954,48
1,85%
Euro vs US Dollar
1,08986
-0,01%
Bitcoin
64.341,67
-0,79%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

  7. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) News

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANPI
DatumZeitQuelleÜberschriftSymbolFirma
18/02/200522h52PR Newswire (US)Angiotech addresses legal proceedingsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
18/02/200518h00PR Newswire (US)Angiotech to webcast conference call discussing year end 2004 financial resultsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
11/02/200522h05PR Newswire (US)Angiotech Pharmaceuticals to participate in CIBC Investor ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
04/02/200515h00PR Newswire (US)Gary Ingenito Joins Angiotech as Senior Vice President, Clinical Development and Regulatory AffairsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
01/02/200522h05PR Newswire (US)Angiotech Pharmaceuticals to participate in Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
01/02/200515h20PR Newswire (US)Angiotech announces joint law suit against Conor MedsystemsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
31/01/200517h40PR Newswire (US)Angiotech partner says physician feedback is extremely positive as it completes initial launch of TAXUS(R) Liberte(TM) paclitaxeNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
24/01/200517h46PR Newswire (US)European Patent office maintains validity of Angiotech's paclitaxel-eluting stent patentNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
19/01/200518h07PR Newswire (US)/C O R R E C T I O N from Source - Angiotech Pharmaceuticals, Inc./NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
19/01/200514h05PR Newswire (US)Angiotech partner announces implantation of millionth TAXUS(R) Express2(TM) coronary stent systemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/01/200517h17PR Newswire (US)Angiotech partner is first to market with next-generation drug-eluting stent systemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
11/01/200515h00PR Newswire (US)Angiotech and Orthovita announce commercial launch of Vitagel(TM)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
05/01/200523h04PR Newswire (US)Angiotech Pharmaceuticals to participate in JP Morgan Healthcare ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/12/200419h38PR Newswire (US)New study shows paclitaxel may benefit Alzheimer's and Parkinson's movement disordersNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
26/11/200420h25PR Newswire (US)Cohesion consolidation updateNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/11/200419h35PR Newswire (US)Boston Scientific Exercises Right to Obtain Exclusive Paclitaxel License From AngiotechNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/11/200419h00PR Newswire (US)Boston Scientific Exercises Rights to Exclusive Coronary LicenseNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/11/200418h49PR Newswire (US)French government expands reimbursement for TAXUS(TM) Express(2)(TM) paclitaxel-eluting stent systemNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
12/11/200415h01PR Newswire (US)Angiotech announces preliminary data from pivotal European gynecology anti-adhesion studyNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
04/11/200422h00PR Newswire (US)Angiotech Pharmaceuticals, Inc. announces results for the third quarter ended September 30, 2004NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
01/11/200414h02PR Newswire (US)Angiotech free to provide exclusive license to Boston ScientificNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
28/10/200420h57PR Newswire (US)Angiotech to webcast conference call discussing third quarter 2004 financial resultsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
27/10/200420h43PR Newswire (US)Angiotech partner announces start of enrollment in ARRIVE 2 drug-eluting stent registryNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
02/10/200400h15PR Newswire (US)Angiotech partner announces 30-day safety data from its TAXUS V drug-eluting stent clinical trialNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
29/09/200418h20PR Newswire (US)Boston Scientific announces two-year follow-up data from TAXUS IV clinical trialNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
29/09/200418h05PR Newswire (US)Boston Scientific announces two-year follow-up data from TAXUS II clinical trialNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
24/09/200417h37PR Newswire (US)Angiotech and Cook Restructure License AgreementNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/09/200423h05PR Newswire (US)Angiotech Pharmaceuticals to participate in UBS Warburg ConferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/09/200416h00PR Newswire (US)Angiotech obtains rights to polymer drug delivery patentsNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
15/09/200423h05PR Newswire (US)Angiotech Pharmaceuticals to participate in Banc of America conferenceNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:ANPI

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
USOTC
ADDYY
Adidas (QX)
CCOM
US500
US 500
FX
EURGBP
Euro vs Sterling
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
NYSE
MRK
Merck
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
TG
DBK
Deutsche Bank
NASDAQ
NVDA
NVIDIA
TG
RHM
Rheinmetall
DBI
TDXP
Tec DAX
TG
D7G
Nel ASA
TG
ALV
Allianz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten